These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8293190)
1. The immunopathology of Alzheimer's disease and some related disorders. Kalaria RN Brain Pathol; 1993 Oct; 3(4):333-47. PubMed ID: 8293190 [TBL] [Abstract][Full Text] [Related]
2. Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Kalaria RN; Harshbarger-Kelly M; Cohen DL; Premkumar DR Neurobiol Aging; 1996; 17(5):687-93. PubMed ID: 8892341 [TBL] [Abstract][Full Text] [Related]
3. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis. Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418 [TBL] [Abstract][Full Text] [Related]
4. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Eikelenboom P; Rozemuller JM; Kraal G; Stam FC; McBride PA; Bruce ME; Fraser H Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):329-36. PubMed ID: 1685040 [TBL] [Abstract][Full Text] [Related]
5. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice. Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538 [TBL] [Abstract][Full Text] [Related]
6. Cellular aspects of the inflammatory response in Alzheimer's disease. Kalaria RN; Cohen DL; Premkumar DR Neurodegeneration; 1996 Dec; 5(4):497-503. PubMed ID: 9117569 [TBL] [Abstract][Full Text] [Related]
7. Microglia and immune activation in Alzheimer's disease. Gordon MN J Fla Med Assoc; 1993 Apr; 80(4):267-70. PubMed ID: 7685046 [TBL] [Abstract][Full Text] [Related]
8. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment. Serpente M; Bonsi R; Scarpini E; Galimberti D Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039 [TBL] [Abstract][Full Text] [Related]
9. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease. Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311 [TBL] [Abstract][Full Text] [Related]
10. Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease. Popović M; Caballero-Bleda M; Puelles L; Popović N Int J Neurosci; 1998 Sep; 95(3-4):203-36. PubMed ID: 9777440 [TBL] [Abstract][Full Text] [Related]
11. MHC class II-positive microglia in human brain: association with Alzheimer lesions. Perlmutter LS; Scott SA; Barrón E; Chui HC J Neurosci Res; 1992 Dec; 33(4):549-58. PubMed ID: 1484388 [TBL] [Abstract][Full Text] [Related]
12. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Eikelenboom P; Veerhuis R Neurobiol Aging; 1996; 17(5):673-80. PubMed ID: 8892339 [TBL] [Abstract][Full Text] [Related]
13. [Alzheimer's disease and the immune system response]. Akiyama H Nihon Rinsho; 1994 Nov; 52(11):2990-4. PubMed ID: 7996699 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint. Marx F; Blasko I; Grubeck-Loebenstein B Arch Immunol Ther Exp (Warsz); 1999; 47(4):205-9. PubMed ID: 10483867 [TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Agostinho P; Cunha RA; Oliveira C Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820 [TBL] [Abstract][Full Text] [Related]
16. Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study. Szpak GM; Lechowicz W; Lewandowska E; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Schmidt-Sidor B; Dymecki J Folia Neuropathol; 2001; 39(3):181-92. PubMed ID: 11770129 [TBL] [Abstract][Full Text] [Related]
17. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches. Ahmad MH; Fatima M; Mondal AC J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170 [TBL] [Abstract][Full Text] [Related]
18. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology. Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468 [TBL] [Abstract][Full Text] [Related]
19. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein. Coria F; Castaño EM; Frangione B Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021 [TBL] [Abstract][Full Text] [Related]
20. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents. Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]